Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in PDSB — PDS Biotechnology Corp

CIK 1390777 NEW YORK, NY
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$60,339
+$18,407 QoQ
Shares Held
68,491
-1.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 52 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. PDSB ranks #293 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in PDSB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,339 68,491
2026-03-31 $41,932 69,311
2025-12-31 $53,368 69,311
2025-09-30 $29,585 29,293
2025-06-30 $38,959 29,293
2025-03-31 $34,858 29,293
2024-12-31 $47,749 29,295
2024-09-30 $111,906 29,295
2024-06-30 $85,833 29,295
2024-03-31 $391,445 98,850
2023-12-31 $535,476 107,742
2023-09-30 $549,570 108,826
2023-06-30 $551,141 109,571
2023-03-31 $267,721 43,532
2022-12-31 $836,628 63,381
2022-09-30 $113,305 38,150
2022-06-30 $139,247 38,150
2022-03-31 $239,905 38,757
2021-12-31 $313,931 38,757
2021-09-30 $577,479 38,757
2021-06-30 $486,400 38,757
2021-03-31 $154,249 33,901
2020-12-31 $77,818 36,364
2020-09-30 $84,728 36,364
2020-06-30 $73,091 36,364
2020-03-31 $26,509 36,365